Cure Alzheimer's Fund Strengthens Leadership with New Board Members to Accelerate Fight Against Alzheimer's

The Cure Alzheimer's Fund has taken a significant step forward in its mission to combat Alzheimer's disease by welcoming three new members to its Board of Directors. Mary Greenhill Cagliero, Mark Faggiano, and Kumar Mahadeva, each with distinguished careers and personal ties to Alzheimer's, join the organization with a shared commitment to eradicating this devastating condition. Their addition underscores the fund's dedication to leveraging diverse expertise and personal passion in the fight against Alzheimer's.

Mary Greenhill Cagliero's background in investment banking and entrepreneurship, combined with her personal loss to Alzheimer's, brings a unique perspective to the board. Similarly, Mark Faggiano's entrepreneurial success and his father's battle with the disease highlight the personal stakes involved in this fight. Kumar Mahadeva's extensive leadership experience in the technology sector, coupled with his own family's experience with Alzheimer's, further enriches the board's capabilities. These appointments signal a robust phase of growth and innovation for the Cure Alzheimer's Fund.

Since its inception in 2004, the Cure Alzheimer's Fund has been at the forefront of funding innovative research, contributing over $223 million to scientific investigations and supporting over 300 leading researchers. The organization's consistent recognition by Charity Navigator with a Four-Star rating reflects its transparency and effective use of donations. The addition of Cagliero, Faggiano, and Mahadeva to the board is expected to amplify the fund's impact, bringing fresh insights and energy to its research initiatives.

The implications of these appointments extend beyond the organization, offering hope to millions affected by Alzheimer's worldwide. By strengthening its leadership with individuals who have both professional excellence and personal motivation, the Cure Alzheimer's Fund is poised to accelerate progress toward finding a cure. This development is a reminder of the critical role that dedicated individuals and organizations play in addressing some of the most challenging health crises of our time.